5Vrzogic P, Pasic A, Podobnik-Takac T. Psoriasis vulgaris and arthritis psoriatica gravis mutilans [J]. Acta Dermatovenerol Croat, 2003, 11(1):22-28.
6McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study [J].Rheumatology, 2003, 42(6): 778-783.
7Galadari H, Fuchs B, Lebwohl M. Newly available treatments for psoriatic arthritis and their impact on skin psoriasis [J]. Int J Dermatol, 2003, 42(3): 231-237.
8Kraan MC,van Kuijk AW,Dinant HJ,et al.Alefacept treatment in psoriatic arthritis:reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis[J].Arthritis Rheum,2002,46:2776-2784.
9Manna SK,Mukhopadhyay A,Aggarwal BB.Leflunomide suppresses TNF-induced cellular responses:effects on NF-kappa B,activator protein-1,c-Jun N-terminal protein kinase,and apoptosis[J].J Immunol,2000,165:5962-5969.
10Gupta AK,Adamiak A,Chow M.Tacrolimus:a review of its use for the management of dermatoses[J].J Eur Acad Dermatol Venereol,2002,16:100-114.
